FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal

The Epoch Times Header

The Food and Drug Administration (FDA) on Friday announced it handed down an emergency use authorization for Eli Lilly and Companyโ€™s bebtelovimab, a monoclonal antibody treatment for COVID-19.

The drug is intended for the treatment of mild to moderate COVID-19, the illness caused by the CCP (Chinese Communist Party) virus in patients aged 12 and older who tested positive for COVID-19 and are โ€œat high risk for progression to severeโ€ disease, including hospitalization or death.

It also applies to individuals for which โ€œalternative COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate,โ€ according to an FDA news release.

โ€œBebtelovimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19,โ€ said the federal drug regulator. โ€œTreatment with bebtelovimab has not been studied in patients hospitalized due to COVID-19. Monoclonal antibodies, such as bebtelovimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation.โ€

The agency and Eli Lilly said that bebtelovimab works by binding with the CCP virus spike protein that causes COVID-19 and is similar to other monoclonal antibodies that have been approved by the FDA and other drug regulators.

Meanwhile, the drug also appears to work against the Omicron subvariant BA.2, which some researchers have said is more contagious than the initial strain, according to the agency.

COVID-19-related hospitalizations and deaths through day 29 for those who received bebtelovimab alone or with other monoclonal antibodies were lower than the placebo rate in previous trials of the drug, the FDA and Eli Lilly said.

โ€œTodayโ€™s action makes available another monoclonal antibody that shows activity against omicron, at a time when we are seeking to further increase supply,โ€ said Patrizia Cavazzoni, M.D, director of the FDAโ€™s Center for Drug Evaluation and Research, in the release. โ€œThis authorization is an important step in meeting the need for more tools to treat patients as new variants of the virus continue to emerge.โ€

Eli Lilly, in a statement released on Feb. 10, announced that it came to an agreement with the federal government to supply 600,000 doses of the drug for $720 million.

โ€œThe supply agreement calls for the delivery of up to 600,000 doses no later than March 31, 2022 with an option of 500,000 additional doses no later than July 31, 2022,โ€ according to the company.

The FDA said that potential side effects include itching, rash, nausea, vomiting, and infusion-related reactions.

By Jack Phillips

Read Original Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Columns

Viewers like you

There is no constitutional authority for any spending on public broadcasting โ€“ period. Any questions: See Article 1, Section 8 of the U.S. Constitution.

Beyond the Trump-Musk fallout?

We are witnessing an unprecedented, unhinged Democrat effort to use lawfare, big Democrat donors, street theater, congressional disruptions, potty-mouth videos, the administrative state, the legacy media, and discredited pollsters to stop the Trump agenda.

Trans-wormal

No worm ever said "I am anthropomorphizing, I am a butterfly" to a toad or flock of geese and expected acknowledgement and support.

In Greenlandโ€™s Icy Capital, Past Troubles Haunt Hopes for the Future

As geopolitical realities and ongoing economic growth raise the stakes, U.S. interest in Greenland and the dream of independence may change things in a big way.

How a Chinese Government Statistician Was Forced to Report Fake Data

Chinese local govt employee produced a non-authorized report on bees and was visited by police and threatened with being sent to a mental hospital.

News

Supreme Court Sides With DOGE in Social Security, Records Cases

The Supreme Court handed DOGE two big wins late on June 6 in its effort to reduce the size of the federal government.

Kilmar Abrego Garcia Returns to US to Face Criminal Charges

Kilmar Abrego Garcia, a citizen of El Salvador, is on his way back to the US, where he will face criminal charges for allegedly smuggling illegal immigrants.

White House Adviser Gives Update on DOGEโ€™s Future Amid Muskโ€“Trump Spat

A top White House adviser said DOGEโ€™s work will likely continue amid a spat between its former chief, Elon Musk, and President Donald Trump.

Trump Administration Asks Supreme Court to Allow Dismantling of Education Department

Trump admin asked Supreme Court to allow it to resume dismantling U.S. Dept of Education, following a lower courtโ€™s previous order halting process.

FTC Warns of Rising Student Loan Scams, Says Fraudsters Took Millions From Borrowers

FTC is warning borrowers to steer clear of student loan debt-relief scams, after shutting down group of companies that allegedly charged millions in illegal fees and left customers worse off.

Walmartโ€™s Drone Delivery Coming to 5 More US Cities

Walmart is set to launch its drone delivery service in five more U.S. cities: Atlanta, Charlotte, Houston, Orlando, and Tampa, the company.

Court Orders Trump Administration to Restore AmeriCorps Funding to States

Federal court ordered Trump admin to restore AmeriCorps funding to states. The ruling comes as part of a lawsuit filed by 24 states and DC.

Tax Deductions You Can Take Without Itemizing

Itโ€™s not always beneficial to itemize. With IRSโ€™s current standard deduction for 2025 most Americans who canโ€™t itemize go with standard deduction.
spot_img

Related Articles